Marina Lalakin
@Sectoral Asset Management Inc
Latest period2024 - Q3ReportedManaged Assets$169.299MTotal holdings90
Assets growth rate-31.19%Assets growth rate (2-Q avg)-17.23%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Sectoral Asset Management Inc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 90 positions.
Assets under management
The assets under management (AUM) of Sectoral Asset Management Inc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 169.299M in assets, with a quarterly growth rate of -31.19% and a 2-quarter average growth rate of -17.23%. The portfolio is managed by Marina Lalakin, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
AMGNAmgen Inc
| 1.35% | $2.284M 7,090 shares@ $322.22 avg price | Decreased -51.76% |
VRTXVertex Pharma
| 1.33% | $2.251M 4,840 shares@ $465.08 avg price | Decreased -44.04% |
ABTAbbott Labs
| 1.31% | $2.212M 19,398 shares@ $114.02 avg price | Decreased -70.71% |
ARGXArgenx Se
| 1.28% | $2.167M 3,997 shares@ $542.09 avg price | Decreased -38.71% |
IQVIqvia Holdings Inc
| 1.07% | $1.801M 7,600 shares@ $236.97 avg price | Decreased -51.28% |
ZLABZai Lab Ltd
| 1.04% | $1.759M 72,870 shares@ $24.15 avg price | Increased 3543.5% |
EWEdwards Lifescience
| 1.01% | $1.706M 25,850 shares@ $66.0 avg price | Increased 65.18% |
PCVXVaxcyte Inc
| 0.99% | $1.661M 14,540 shares@ $114.28 avg price | Decreased -56.89% |
CVSCvs Health Corp
| 0.95% | $1.603M 25,500 shares@ $62.88 avg price | Decreased -34.61% |
BNTXBiontech Se
| 0.93% | $1.562M 13,155 shares@ $118.77 avg price | Decreased -51.75% |